Masimo | MASI - Ebitda

Prezzo Delle Azioni
178.48
Cambio Giornaliero
-0.01 -0.01%
Mensile
0.10%
Annuale
16.21%
Q2 Previsione
174.77




Ebitda Cambiamento Data
Abbott USD 3.27B 178M 2025-12
Accuray USD -685K 900K 2024-09
Align Technology USD 260.87M 77.03M 2025-12
AngioDynamics USD 5.94M 3.78M 2025-09
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 17.07M 2.79M 2026-03
Avanos Medical USD 13M 3M 2025-12
Baxter International USD -447M 873M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
General Electric Aerospace USD 2.84B 568M 2026-03
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 94.78M 20.75M 2025-12
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intuitive Surgical USD 1.09B 165.5M 2025-12
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Orthofix International USD 27.88M 2.77M 2025-12
Owens Minor USD 90.02M 2.15M 2025-12
ResMed USD 547.48M 27.46M 2025-12
Steris USD 389.7M 22.5M 2025-09
Stryker USD 1.57B 618M 2026-03
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD 247.07M 575.88M 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12